BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 25566754)

  • 1. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Gardiner SJ; Gavranich JB; Chang AB
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD004875. PubMed ID: 25566754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Mulholland S; Gavranich JB; Gillies MB; Chang AB
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004875. PubMed ID: 22972079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Mulholland S; Gavranich JB; Chang AB
    Cochrane Database Syst Rev; 2010 Jul; (7):CD004875. PubMed ID: 20614439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics for community acquired lower respiratory tract infections (LRTI) secondary to Mycoplasma pneumoniae in children.
    Gavranich JB; Chang AB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004875. PubMed ID: 16034954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin for acute lower respiratory tract infections.
    Laopaiboon M; Panpanich R; Swa Mya K
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD001954. PubMed ID: 25749735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin for acute lower respiratory tract infections.
    Panpanich R; Lerttrakarnnon P; Laopaiboon M
    Cochrane Database Syst Rev; 2008 Jan; (1):CD001954. PubMed ID: 18253999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of mycoplasma pneumonia: a systematic review.
    Biondi E; McCulloh R; Alverson B; Klein A; Dixon A; Ralston S
    Pediatrics; 2014 Jun; 133(6):1081-90. PubMed ID: 24864174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin for acute lower respiratory tract infections.
    Panpanich R; Lerttrakarnnon P; Laopaiboon M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD001954. PubMed ID: 15497172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.
    Harris JA; Kolokathis A; Campbell M; Cassell GH; Hammerschlag MR
    Pediatr Infect Dis J; 1998 Oct; 17(10):865-71. PubMed ID: 9802626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
    Sáez-Llorens X; Castaño E; Wubbel L; Castrejón MM; de Morales I; Vallarino D; de Atencio I; Muñiz L; Olsen K; McCracken GH
    Rev Med Panama; 1998 Sep; 23(2):27-33. PubMed ID: 11214557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics for community-acquired pneumonia in adult outpatients.
    Pakhale S; Mulpuru S; Verheij TJ; Kochen MM; Rohde GG; Bjerre LM
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD002109. PubMed ID: 25300166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Normansell R; Maisey S; Poole P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide antibiotics for bronchiectasis.
    Kelly C; Chalmers JD; Crossingham I; Relph N; Felix LM; Evans DJ; Milan SJ; Spencer S
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012406. PubMed ID: 29543980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for treating genital Chlamydia trachomatis infection in pregnancy.
    Cluver C; Novikova N; Eriksson DO; Bengtsson K; Lingman GK
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD010485. PubMed ID: 28937705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia.
    Wang K; Gill P; Perera R; Thomson A; Mant D; Harnden A
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD009175. PubMed ID: 23076954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections.
    Soepandi P; Mangunnegoro H; Yunus F; Gunawan J
    Respirology; 1998 Jun; 3(2):113-7. PubMed ID: 9692520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics for prolonged wet cough in children.
    Marchant JM; Petsky HL; Morris PS; Chang AB
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD004822. PubMed ID: 30062732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology and treatment of community-acquired pneumonia in ambulatory children.
    Wubbel L; Muniz L; Ahmed A; Trujillo M; Carubelli C; McCoig C; Abramo T; Leinonen M; McCracken GH
    Pediatr Infect Dis J; 1999 Feb; 18(2):98-104. PubMed ID: 10048679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
    Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
    BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events in people taking macrolide antibiotics versus placebo for any indication.
    Hansen MP; Scott AM; McCullough A; Thorning S; Aronson JK; Beller EM; Glasziou PP; Hoffmann TC; Clark J; Del Mar CB
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011825. PubMed ID: 30656650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.